Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 22 of 25
Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
NCT00209092
Identifying Factors That Predict Antidepressant Treatment Response
NCT00360399
Imaging Predictors of Treatment Response in Depression
NCT00367341
Insulin Infusion in the Hospital Wards
NCT00412347
FFA-Induced Hypertension and Endothelial Dysfunction
NCT00589888
Respiratory Motion Analysis in Children With MRI
NCT00367354
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
NCT00400205
Age and Endothelial Progenitor Cell Mobilization
NCT00585949
Discrete Hypothermia in the Management of Traumatic Brain Injury
NCT00676104
Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma (Asthma-Bariatric Surgery Study)
NCT00615498
Calcium/Vitamin D, Biomarkers & Colon Polyp Prevention
NCT00399607
Yellow Fever Virus Vaccine and Immune Globulin Study
NCT00254826
Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU
NCT00394524
Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)
NCT00321503
To Compare the Ischemic Pre-conditioning and Post-conditioning on Reperfusion Injury in Humans.
NCT00385151
B-type Natriuretic Peptide in the Non-Cardiac Pediatric Patient
NCT00330811
Assessment of Translesional Markers and Metabolomics
NCT00321139
Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)
NCT00743756
Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
NCT00313339
Predictive Medicine Research
NCT00384761
Efficacy of DBM on Fractures of the Shinbone (Tibia)
NCT00299052
Infectivity of Norovirus in Groundwater-Human Challenge Study
NCT00313404
Predictive Medicine Research. (PRE MED)
NCT00336570
Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD
NCT00605007
A Retrospective Analysis of the Predictive Potential of Pre-operative
NCT00321282
Pro-Calcitonin Levels Following Pediatric Cardiac Surgery
NCT00284570
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
NCT00288444
SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease
NCT00257543
Risperdal Consta and Health Care Utilization in Patients With Schizophrenia
NCT00313391
Islet Transplantation Using Abatacept
NCT00276250
Partnership Programs to Reduce Cardiovascular Disparities- Morehouse- Emory Partnership
NCT00336869
Heparin Management During Cardiopulmonary Bypass in Children
NCT00146653
A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers
NCT00321945
A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias
NCT00321204
Comparison of Immune Response Following Surgical Management of Renal Tumors
NCT00289146
Multisite Feeding Study: Home Surveillance and Feeding Strategies in Infants With Complex Single Ventricle
NCT00257517
Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.
NCT00239603
Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer
NCT00239551
Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
NCT00252967
Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD
NCT00228631
Tissue Doppler Echo Imaging of Heart Function After Transplant
NCT00208650
Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes
NCT00394407
Using Tissue Doppler/Synchronization to Determine Heart Function in Children With Congenital Heart Disease
NCT00208676
Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy
NCT00140491
NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn
NCT00139217
Outcomes Following Medical or Surgical Management of Endocarditis
NCT00166023
Antepartum Betamethasone Treatment for Prevention of Respiratory Distress in Infants Born by Elective Cesarean Section
NCT00139256
Outcomes Following Pulmonary Valve Replacement in Adults
NCT00276237
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione
NCT00228644
Herpesvirus in Idiopathic Pulmonary Fibrosis
NCT00228670
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.